RE:Revenue comparison 10 years laterThere is about 5 times as many shares of Knight so we are close to being halfway there I would think. If revenue is 80+ for this quarter there is a good chance 300 is within grasp for this year.
Ebitda will start to be large enough so there maybe interest from others so some share price increase is visual .
As new drugs and territories are added into the mix now , price drops like this will be looked upon as opportunities for stock buybacks and adding to positions by investors .
Even with the stock being down we are seeing higher lows.
It looks as though there is a base here. Still not a lot of volume.
Short positions have shrunk by almost a million shares since July 15.
This latest market downturn is a concern but all things end .
On the bright side we have the bashers to keep us amused while we wait.
I am looking forward to when a reasonable argument is going to be offered as to Why Not instead of Mugs is a Poo Poo (oops inside voice again)